Kinetic and Mechanistic Study of the pH-Dependent Activation (Epoxidation) of Prodrug Treosulfan Including the Reaction Inhibition in a Borate Buffer.
A prodrug treosulfan (T) undergoes a pH-dependent activation to epoxide derivatives. The process seems to involve an intramolecular Williamson reaction (IWR) but clear kinetic evidence is lacking. Moreover, a cis-diol system present in the T structure is expected to promote complexation with boric acid. As a result, the prodrug epoxidation would be inhibited; however, this phenomenon has not been investigated. In this article, the effect of pH on the kinetics of T conversion to its monoepoxide was studied from a mechanistic point of view. Also, the influence of boric acid on the reaction kinetics was examined. The rate constants observed for the activation of T (kobs) in acetate, phosphate, and carbonate buffers satisfied the equation logkobs= -7.48 + 0.96 pH. The reaction was inhibited in the excess of boric acid over T, and the kobsdecreased with increasing borate buffer concentration. The experimental results were consistent with the inhibition model that included the formation of a tetrahedral, anionic T-boric acid monoester. To conclude, in nonborate buffers, the T activation to (2S,3S)-1,2-epoxybutane-3,4-diol 4-methanesulfonate follows IWR mechanism. A borate buffer changes the reaction kinetics and complicates kinetic analysis.
Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 6 Swiecickiego Street, Poznan 60-781, Poland. Electronic address: michalroman@ump.edu.pl.
Michał
M
Romański
Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 6 Swiecickiego Street, Poznan 60-781, Poland.
Whitney
W
Ratajczak
Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 6 Swiecickiego Street, Poznan 60-781, Poland.
Franciszek
F
Główka
D018906:Antineoplastic Agents, Alkylating / Q000378:metabolism*; D001881:Borates / Q000378:metabolism; D002021:Buffers; D002066:Busulfan / Q000031:analogs & derivatives* / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D004852:Epoxy Compounds / Q000378:metabolism*; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D011355:Prodrugs / Q000378:metabolism*
D018906:Antineoplastic Agents, Alkylating; D001881:Borates; D002021:Buffers; D004852:Epoxy Compounds; D011355:Prodrugs; C027488:1,2-epoxybutane; C018404:treosulfan; D002066:Busulfan
HPLC; chemical stability; complexation; kinetics; prodrugs